Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Testosterone Products Need Post-Market Cardiovascular Trial

Mar 04 2015

• By Sarah Karlin-Smith

Related Content

The Next Estrogen Or An Off-Label Star: Can FDA Turn Back The Clock On Testosterone?

Sep 22 2014

Disease-Awareness Ads Thrive In Regulatory No-Man’s Land

Sep 29 2014

Product Liability Suits: Testosterone, Lipitor Grow While Yaz, Pradaxa Settle

Jan 19 2015

Related Companies

Eli Lilly and Company

AbbVie Inc.

Teva Pharmaceutical Industries Ltd.

Endo, Inc.

Auxilium Pharmaceuticals, Inc.

Eli Lilly and Company

Acerus Pharmaceuticals Corporation

Sawai Pharmaceutical Co., Ltd.

Clarus Therapeutics Holdings, Inc.

Repros Therapeutics, Inc.

TesoRx Pharma, LLC.

Additional Topics

United States Clinical Trials Regulation Post Market Regulation & Studies Safety BioPharmaceutical

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window